Journal articleImmun Inflamm Dis2026
Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer.
- Journal
- Immun Inflamm Dis
- Published
- 1 October 2026
- Citations
- 0
- Type
- Article
- License
- cc by
- Full text
- Open access, reuse-licensed (cc by)
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.
Try
Trials 4
- Builds on itImmunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer. NCT05116917↗
- Builds on itIpilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer NCT04258150↗
- Builds on itStudy of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients NCT02767557↗
- Builds on itImmune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients NCT02866383↗